Shares in GSK lost 8% of their value today in the wake of the analyst comments, while Sanofi fell 3% and Haleon was down 6%, collectively wiping tens of billions of dollars off their valuations.
Most readers would already know that Haleon's (LON:HLN) stock increased by 3.9% over the past week. However, we decided to study the company's mixed-bag of fundamentals to assess what this could ...
Global consumer healthcare business, Haleon – parent brand of Panadol, Voltaren, and Centrum, among others – has appointed a marketing director for Australia and New Zealand. Announced on ...
Global consumer health company Haleon has appointed Nagraj Iyer as marketing director for Australia and New Zealand. Prior to his most recent role as Haleon's marketing director for North Asia ...
The Haleon UK Capital PLC-Bond has a maturity date of 3/29/2038 and offers a coupon of 3.3750%. The payment of the coupon will take place 1.0 times per Year on the 29.03.. At the current price of ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are ...